Treatment for hepatitis C has improved substantially with the availability of direct antigen antiviral therapy, which results in eradication of the virus in approximately 90% of persons in 8 to 12 weeks of treatment.1 However, it can be particularly challenging to provide treatment for persons who inject drugs because the US health care system is not oriented around the needs of this population.